Hypoechogenicity of the midbrain raphe detected by transcranial sonography: an imaging biomarker for depression in migraine patients

Background: The high comorbidity of migraine and depression is suggestive of shared risk factors or common mechanisms between the two diseases. In individuals with a depressive disorder, there is a high prevalence of altered midbrain raphe (MBR) echogenicity, detectable via transcranial sonography (...

Full description

Bibliographic Details
Main Authors: YiShui Zhang, Ying Liu, Ruoyun Han, Kangding Liu, Yingqi Xing
Format: Article
Language:English
Published: SAGE Publishing 2021-04-01
Series:Therapeutic Advances in Neurological Disorders
Online Access:https://doi.org/10.1177/17562864211007708
_version_ 1819140440944803840
author YiShui Zhang
Ying Liu
Ruoyun Han
Kangding Liu
Yingqi Xing
author_facet YiShui Zhang
Ying Liu
Ruoyun Han
Kangding Liu
Yingqi Xing
author_sort YiShui Zhang
collection DOAJ
description Background: The high comorbidity of migraine and depression is suggestive of shared risk factors or common mechanisms between the two diseases. In individuals with a depressive disorder, there is a high prevalence of altered midbrain raphe (MBR) echogenicity, detectable via transcranial sonography (TCS), that is suggested to be linked with a dysfunction of the serotoninergic system. In patients with migraine, this alteration has seldom been explored in earlier studies, and conclusions are often lacking. Our study aimed to elucidate whether this alteration is specific to migraine and to determine whether it is related with depression. Methods: This study enrolled patients with migraine ( n  = 100, 72% female) and patients with tension-type headache disorders (TTH) ( n  = 62, 78.5% female) from a headache clinic. In addition, 79 healthy subjects (79.7% female) were recruited as controls. All participants underwent a standard interview to evaluate headache information and an interview with psychiatrists for depression evaluation. TCS examinations were performed on all participants. Results: Patients with migraine had a higher rate of MBR hypoechogenicity (28%) compared with that of healthy controls (15.2%) and that of patients with TTH (12.9%). In patients with migraine, reduced MBR echogenicity was associated with depressive symptoms assessed using the Hamilton Depression Rating Scale (HAM-D). No association between migraine self-medication and MBR echogenicity was found. Conclusion: Reduced-echoic MBR detected by TCS is prevalent in migraine patients and is associated with depressive symptoms. TCS-detected hypoechogenic MBR abnormality could be an imaging biomarker of depressive symptoms in patients with migraine.
first_indexed 2024-12-22T11:38:36Z
format Article
id doaj.art-f113d38f36c8426db177fd3258e3dc90
institution Directory Open Access Journal
issn 1756-2864
language English
last_indexed 2024-12-22T11:38:36Z
publishDate 2021-04-01
publisher SAGE Publishing
record_format Article
series Therapeutic Advances in Neurological Disorders
spelling doaj.art-f113d38f36c8426db177fd3258e3dc902022-12-21T18:27:21ZengSAGE PublishingTherapeutic Advances in Neurological Disorders1756-28642021-04-011410.1177/17562864211007708Hypoechogenicity of the midbrain raphe detected by transcranial sonography: an imaging biomarker for depression in migraine patientsYiShui ZhangYing LiuRuoyun HanKangding LiuYingqi XingBackground: The high comorbidity of migraine and depression is suggestive of shared risk factors or common mechanisms between the two diseases. In individuals with a depressive disorder, there is a high prevalence of altered midbrain raphe (MBR) echogenicity, detectable via transcranial sonography (TCS), that is suggested to be linked with a dysfunction of the serotoninergic system. In patients with migraine, this alteration has seldom been explored in earlier studies, and conclusions are often lacking. Our study aimed to elucidate whether this alteration is specific to migraine and to determine whether it is related with depression. Methods: This study enrolled patients with migraine ( n  = 100, 72% female) and patients with tension-type headache disorders (TTH) ( n  = 62, 78.5% female) from a headache clinic. In addition, 79 healthy subjects (79.7% female) were recruited as controls. All participants underwent a standard interview to evaluate headache information and an interview with psychiatrists for depression evaluation. TCS examinations were performed on all participants. Results: Patients with migraine had a higher rate of MBR hypoechogenicity (28%) compared with that of healthy controls (15.2%) and that of patients with TTH (12.9%). In patients with migraine, reduced MBR echogenicity was associated with depressive symptoms assessed using the Hamilton Depression Rating Scale (HAM-D). No association between migraine self-medication and MBR echogenicity was found. Conclusion: Reduced-echoic MBR detected by TCS is prevalent in migraine patients and is associated with depressive symptoms. TCS-detected hypoechogenic MBR abnormality could be an imaging biomarker of depressive symptoms in patients with migraine.https://doi.org/10.1177/17562864211007708
spellingShingle YiShui Zhang
Ying Liu
Ruoyun Han
Kangding Liu
Yingqi Xing
Hypoechogenicity of the midbrain raphe detected by transcranial sonography: an imaging biomarker for depression in migraine patients
Therapeutic Advances in Neurological Disorders
title Hypoechogenicity of the midbrain raphe detected by transcranial sonography: an imaging biomarker for depression in migraine patients
title_full Hypoechogenicity of the midbrain raphe detected by transcranial sonography: an imaging biomarker for depression in migraine patients
title_fullStr Hypoechogenicity of the midbrain raphe detected by transcranial sonography: an imaging biomarker for depression in migraine patients
title_full_unstemmed Hypoechogenicity of the midbrain raphe detected by transcranial sonography: an imaging biomarker for depression in migraine patients
title_short Hypoechogenicity of the midbrain raphe detected by transcranial sonography: an imaging biomarker for depression in migraine patients
title_sort hypoechogenicity of the midbrain raphe detected by transcranial sonography an imaging biomarker for depression in migraine patients
url https://doi.org/10.1177/17562864211007708
work_keys_str_mv AT yishuizhang hypoechogenicityofthemidbrainraphedetectedbytranscranialsonographyanimagingbiomarkerfordepressioninmigrainepatients
AT yingliu hypoechogenicityofthemidbrainraphedetectedbytranscranialsonographyanimagingbiomarkerfordepressioninmigrainepatients
AT ruoyunhan hypoechogenicityofthemidbrainraphedetectedbytranscranialsonographyanimagingbiomarkerfordepressioninmigrainepatients
AT kangdingliu hypoechogenicityofthemidbrainraphedetectedbytranscranialsonographyanimagingbiomarkerfordepressioninmigrainepatients
AT yingqixing hypoechogenicityofthemidbrainraphedetectedbytranscranialsonographyanimagingbiomarkerfordepressioninmigrainepatients